Literature DB >> 31527980

Hepatic Encephalopathy in the Hospitalized Patient: A Review for Hospitalists.

Harleen Kaur Chela1, Nishchayjit Basra1, S Hasan Naqvi1.   

Abstract

Hepatic encephalopathy is a well-recognized complication of decompensated cirrhosis. It is a reversible state of neurocognitive decline, the etiology of which is multifactorial. Diagnosis is predominantly clinical and usually a diagnosis of exclusion. The identification of precipitating factors and their correction is an essential part of the management along with medical therapies such as lactulose and rifaxmin.

Entities:  

Mesh:

Year:  2019        PMID: 31527980      PMCID: PMC6699823     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  24 in total

1.  Helicobacter pylori, harmful to the brain?

Authors:  A T Blei
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

Review 2.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 3.  Blood ammonia levels and hepatic encephalopathy.

Authors:  Alan H Lockwood
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

4.  Helicobacter pylori infection induces hyperammonaemia in Mongolian gerbils with liver cirrhosis.

Authors:  H Suto; T Azuma; S Ito; M Ohtani; M Dojo; Y Ito; Y Kohli; M Kuriyama
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

Review 5.  Pathophysiology of septic encephalopathy: a review.

Authors:  M C Papadopoulos; D C Davies; R F Moss; D Tighe; E D Bennett
Journal:  Crit Care Med       Date:  2000-08       Impact factor: 7.598

Review 6.  Review article: the burden of hepatic encephalopathy.

Authors:  F F Poordad
Journal:  Aliment Pharmacol Ther       Date:  2007-02       Impact factor: 8.171

7.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

Review 8.  Ammonia neurotoxicity and the mitochondrial permeability transition.

Authors:  M D Norenberg; K V Rama Rao; A R Jayakumar
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

9.  Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy.

Authors:  E Strauss; R Tramote; E P Silva; W R Caly; N Z Honain; R A Maffei; M F de Sá
Journal:  Hepatogastroenterology       Date:  1992-12

Review 10.  Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines.

Authors:  Christopher Randolph; Robin Hilsabeck; Ainobu Kato; Parampreet Kharbanda; Yu-Yuan Li; Daniela Mapelli; Lisa D Ravdin; Manuel Romero-Gomez; Andrea Stracciari; Karin Weissenborn
Journal:  Liver Int       Date:  2009-03-19       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.